Skip to main content

Animations

MJFF Publications

3331 - 3340 of 9134 Results
Title
Year
  • Year
  • 2013
  • 2014
  • 2014
  • 2014
  • 2014
  • 2019
  • 2025
  • 2012
  • 2023
  • 2014
  • Summary Details
    OPEN
    Title: Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1312701111
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1321845111
    Citation Count: 215
  • Summary Details
    OPEN
    Title: Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1321785111
    Citation Count: 343
  • Summary Details
    OPEN
    Title: Parkinson disease-associated mutation R1441H in LRRK2 prolongs the “active state” of its GTPase domain
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1323285111
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Concomitant pathologies among a spectrum of parkinsonian disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012
    Citation Count: 164
  • Hypertension and progressive supranuclear palsy
    2019
    Summary Details
    RESTRICTED
    Title: Hypertension and progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.036
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Benchmarking macaque brain gene expression for horizontal and vertical translation
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.ads6967
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/564812
    Citation Count: 4
  • Summary Details
    OPEN
    Title: International Genetic Testing and Counseling Practices for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29442
    Citation Count: 16
  • Summary Details
    OPEN
    Title: AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.09.013
    Citation Count: 70
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.